Sionna Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
SION Nasdaq 2836 www.sionnatx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Sionna Therapeutics, Inc.

Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences - Nov 2nd, 2026 6:00 am
Sionna Therapeutics, Inc. (SION) Loses 37.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Oct 12th, 2026 6:35 am
Sionna Therapeutics to Present Data at the 2026 North American Cystic Fibrosis Conference - Oct 8th, 2026 2:30 pm
Sionna Therapeutics (SION) Approves 46% Job Cut. Can a New Trial Make its Cash More Productive? - Sep 17th, 2026 3:21 pm
SION to Cut Workforce by Nearly Half After CF Study Failure, Stock Down - Sep 16th, 2026 9:26 am
FDA clears first generic radioligand drug; Sionna turns to layoffs - Sep 15th, 2026 11:13 am
Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial - Sep 14th, 2026 2:01 pm
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead - Aug 20th, 2026 1:50 pm
Sionna Therapeutics (SION) Resets After Trial Miss, Is The Discount Now Too Deep? - Aug 13th, 2026 3:11 am
Sionna Therapeutics (SION) Is Down 86.8% After Halting SION-719 And Refocusing Its CF Pipeline – Has The Bull Case Changed? - Aug 12th, 2026 11:13 pm
Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says - Aug 12th, 2026 9:02 am
Sionna Therapeutics (SION) Stock Still Looks Cheap After The 90% Fall - Aug 12th, 2026 4:12 am
One Company’s Clinical Miss Is Another’s Moat: Vertex Rallies as Sionna’s CF Bet Collapses - Aug 11th, 2026 9:41 pm
Sionna Therapeutics stock falls 92% after SION-719 trial failure - Aug 11th, 2026 7:11 am
Sionna Therapeutics (SION) Halts Lead Cystic Fibrosis Drug After Phase 2 Failure - Aug 11th, 2026 2:12 am
Sionna Halts SION-719 After Phase 2a Miss, Eyes SION-451 Combination Path - Aug 10th, 2026 10:03 pm
Immunic appoints Elena Ridloff to board of directors - Aug 10th, 2026 2:36 pm
Why Vertex Pharma Popped, As A Key Rival Plummeted 92% - Aug 10th, 2026 2:04 pm
Why Sionna Therapeutics Stock Is Crashing 91% to a Record Low - Aug 10th, 2026 1:14 pm
SION Stock On Track For Worst Day Ever After 90% Drop — What’s Driving The Selloff? - Aug 10th, 2026 11:18 am